Navigation Links
Onyx Pharmaceuticals Reports Third Quarter 2010 Financial Results; Japan License Leverages Worldwide Potential of Carfilzomib and Contributes $59.2 Million of License Revenue
Date:11/3/2010

o obligation to update publicly any forward-looking statements to reflect new information, events, or circumstances after the date of this release except as required by law.

(See attached tables.)ONYX PHARMACEUTICALS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(In thousands, except per share amounts)

(unaudited)Three Months EndedNine Months EndedSeptember 30,September 30,2010200920102009Revenue: Revenue from collaboration agreement$
3,696$
9,137$   195,372$   183,074License revenue59,165-59,165-Total operating revenue122,86169,137254,537183,074Operating expenses:Research and development (1)44,56835,635131,39492,478Selling, general and administrative (1)25,92423,44077,29368,899Contingent consideration5,622-101,107-Total operating expenses76,11459,075309,794161,377Income (loss) from operations46,74710,062(55,257)21,697Investment income6281,0152,1983,108Interest expense (4,943)(2,255)(14,467)(2,255)Other expense(862)-(862)-Income (loss) before provision (benefit) for income taxes41,5708,822(68,388)22,550Provision (benefit) for income taxes70589(662)878Net income (loss)$
41,500$
8,233$   (67,726)$
21,672Net income (loss) per share:Basic$
.66$
.14$
(1.08)$
.37Diluted (2)$
.66$
.14$
(1.08)$
.37Computation of diluted shares:Basic 62,70760,24862,56258,201Dilutive effect of options142376-310Diluted (2)62,84960,62462,56258,511(1)  Includes employee stock-based compensation charges of:Research and development$
,075$
517$
3,090$
2,286Selling, general, and administrative4,7994,45513,50212,647Total employee stock-based compensation$
5,874$
4,972$
,592$
4,933(
2) Under the "if-converted" method, interest and issuance costs and potential common shares related to the Company's convertible senior notes were excluded in the computation of diluted per share amounts for the three and nine months ended September 30, 2010 and 2009 bec
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Vanda Pharmaceuticals Reports Third Quarter 2010 Results
2. OncoMed Pharmaceuticals Awarded Five Therapeutic Discovery Project Grants Totaling $1.2 Million
3. Transcept Pharmaceuticals to Report Third Quarter 2010 Results and Host Conference Call on November 11, 2010
4. Anthera Pharmaceuticals Reports 2010 Third Quarter Financial Results and Operational Update
5. ISTA Pharmaceuticals Reports Third Quarter 2010 Financial Results
6. DUSA Pharmaceuticals, Inc.® to Host Third Quarter 2010 Corporate Highlights and Financial Results Conference Call
7. Access Pharmaceuticals Awarded $1.5 Million in Section 48D Grants
8. Anadys Pharmaceuticals to Report Third Quarter 2010 Financial Results
9. Alder Biopharmaceuticals Appoints Bruce Montgomery to Board of Directors
10. Alexza Pharmaceuticals to Announce 2010 Third Quarter Financial Results on November 9, 2010
11. AVANIR Pharmaceuticals Invites Investors to Conference Call Regarding FDA Approval of NUEDEXTA™ on Monday November 1, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... Dec. 15, 2014  Inovio Pharmaceuticals, Inc. (NASDAQ: ... been added to the NASDAQ Biotechnology Index (NBI). ... become effective upon market open on December 22, ... designed to track the performance of a set ... biotechnology or pharmaceutical according to the Industry Classification ...
(Date:12/15/2014)...  Stephen Squires, CEO and founder of leading North ... (OTCQB:QTMM), will be speaking at the launch event for ... 16th, 2014. The RCQM launch continues Rice University,s leadership ... faculty and students and by inviting the world,s leading ... "We have a long association with Rice University ...
(Date:12/13/2014)... 11, 2014 Research and Markets ... the "Drug Injection Devices to 2020" ... http://photos.prnewswire.com/prnh/20130307/600769 As new drugs ... list of health conditions, drug developers have increasingly ... administration process and increase the efficiency and reliability ...
Breaking Medicine Technology:Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index 2Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index 3Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index 4Quantum Materials CEO Stephen Squires to Speak at Rice Center for Quantum Materials Launch 2Quantum Materials CEO Stephen Squires to Speak at Rice Center for Quantum Materials Launch 3Drug Injection Devices to 2020 2Drug Injection Devices to 2020 3Drug Injection Devices to 2020 4
... UPI ) announced today that it will release financial ... at the market close on Monday, November 2, 2009. ... results on Monday, November 2, 2009 at 3:30 p.m. Central ... Medi Jiwani, Vice President, Chief Financial Officer and Treasurer, will ...
... 21 Shire plc,(LSE: SHP, NASDAQ: SHPGY ), ... Biologics License Application (BLA) with the U.S.,Food and Drug ... for Fabry disease, by the end of the year. ... filed at the,request of FDA, has been approved, and ...
Cached Medicine Technology:Uroplasty to Issue Second Fiscal Quarter Results on November 2, 2009 2Shire Targets Fourth Quarter Filing of BLA for REPLAGAL(R) for Fabry Disease With U.S. FDA 2Shire Targets Fourth Quarter Filing of BLA for REPLAGAL(R) for Fabry Disease With U.S. FDA 3Shire Targets Fourth Quarter Filing of BLA for REPLAGAL(R) for Fabry Disease With U.S. FDA 4
(Date:12/17/2014)... -- Expectant parents should leave prenatal picture-taking to medical ... Use of ultrasound imaging and heartbeat monitors to get ... agency warns. "Although there is a lack ... and heartbeat monitors, prudent use of these devices by ... FDA biomedical engineer, said in an agency news release. ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, ... America, and work commitment is a big reason why, new ... said Dr. Mathias Basner, an assistant professor of sleep and ... of Medicine. A time-use survey of nearly 125,000 Americans, ... main activity exchanged for sleep. Short sleepers -- those who ...
(Date:12/15/2014)... 15, 2014 South Florida’s leading urgent care ... can be a daze of hassle, hustle, and bustle that ... decking halls, to burns when making special meals and heartburn ... can happen at any time. To prevent this season of ... made a list of helpful and healthful holiday tips to ...
(Date:12/15/2014)... News) -- Expert pilots process visual information more efficiently ... better decisions during landings, a new study shows. ... pilots to master, and 36 percent of all airplane ... final approach and landing. Researchers monitored the brain ... pilots while they were at the controls of a ...
(Date:12/15/2014)... 15, 2014 At the leading, long-established ... AutismOne and Focus Autism will welcome ... research on the effects of toxins to children’s health, ... information. , Luminaries such as Dr. Lucija Tomljenovic ... with esteemed, credentialed colleagues of the United States to ...
Breaking Medicine News(10 mins):Health News:FDA Warns Against Fetal 'Keepsake' Videos 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:Study Shows Why Expert Pilots Are Experts 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 3
... (FHC) has received an initial order for the supply ... AIDS Control Organisation (NACO). ,"The condoms will be ... and distribution will initially be focused on commercial sex ... Pradesh, Karnataka, Maharastra) in India," said a statement issued ...
... A new study has pointed out the alarming incidence of ... more than 25 million people, approximating// to one-fifth of the ... stroke. ,In view of this health threat, the ... in the diet and do more exercise, if these effects ...
... officials, investigating the incidence of fungal infection in Bausch and ... the infection. The only association arrived at is that nearly ... used a lens cleansing solution, manufactured by Bausch and Lomb. ... contact lens and lens solution, feels that the cause of ...
... have revealed that cooked tomatoes contain an ingredient called ... cardiovascular disease// . ,Lycopene, is a bright ... other red fruits. Lycopene is the most common carotenoid ... most potent carotenoid antioxidants. ,Besides tomatoes other ...
... nation’s first test tube babies, both girls, as a testament ... as Agnes and as Jane are overjoyed and are in ... 300,000 Kenyan shillings (?2,275) for the now rather commonplace in ... Louise Brown was born in Oldham, U.K on July 25, ...
... had warned that office workers sit at their computer screens ... of being affected by deep vein thrombosis. ,This ... Bristol almost died after a 12-hour stint in front of ... the first cases in the UK of a growing phenomenon ...
Cached Medicine News:Health News:US Firm To Supply Female Condoms To India 2Health News:Testtube Babies Born in Kenya 2
... Special Low-profile Hourglass Jaw Design ... Through A Minimal Incision.,Mirror Polished Blades ... Acting Handle Mechanism Offers Control Over ... Prevent The Lens From Tilting During ...
... Opening Is Designed To Pinch And ... A Separate Cystotome. The 11mm Jaws Are Formed,To ... Incision.,The Distal Jaws Have Platforms, And The Proximal ... Pick Up Of Iris. The Unique Jaw Structures ...
2.5V Halogen source, fiber-optic delivery, 3X magnification, pocket-sized....
... offer patented Sensomatic® handles that ... up and switch off when ... of light from 2.5V halogen ... of examination area. Used ...
Medicine Products: